- This event has passed.
Conducting Cancer Clinical Trials In East Africa Are We Ready?
SPEAKER PROFILES:
Professor Mansoor Saleh
Mansoor Saleh, MD received his early education in the Aga Khan School system in East Africa, his medical education at the University of Heidelberg in Germany and conducted his doctoral research at the Max Planck Institute for Medical Research in Heidelberg. He received his training in internal medicine at the Henry Ford Hospital in Detroit Michigan and clinical and translational research training in Hematology & Oncology at the University of Alabama Comprehensive Cancer Center in Birmingham, Alabama where he was tenured Professor of Medicine & Pathology and Director of the First-in-Human Early Drug Development Program.
His area of research and clinical focus is “targeted therapy of cancer”. In January 2020, he joined the Aga Khan University in Nairobi, Kenya as the Founding Chair, Department of Hematology – Oncology and Founding Director – AKU, N Cancer Center.
Moderator: Dr Sitna Mwanzi
Sitna Ali Mwanzi is a consultant medical oncologist working at the Kenyatta National Hospital in Nairobi Kenya. She obtained her Bachelor of Medicine and Surgery from the University of Nairobi and Master of Medicine in Internal Medicine from the Aga Khan University Hospital, Nairobi. She undertook a fellowship in Medical Oncology at Barts Health NHS Trust in the United Kingdom attaining a Specialist Certificate in Medical Oncology from the Royal College of Physicians and Association of Cancer Physicians in the United Kingdom. She also has a Master of Science in Advanced Oncology from Ulm University in Germany.
Her research interests include breast cancer, lung cancer, prostate cancer, chronic myeloid leukemia and cervical cancer. She is passionate about increasing health care workers and general public awareness about cancer, role of screening, early diagnosis and treatment of cancer. She works closely with the National Cancer Control Program in implementation of the National Cancer Control Strategy and advising on cancer policy for improving access to cancer care.